Obesity and Coronary Artery Calcium in Diabetes: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study

被引:33
作者
Rodrigues, Ticiana C. [1 ,3 ]
Veyna, Adrienne M. [1 ]
Haarhues, Michelle D. [1 ]
Kinney, Gregory L. [1 ]
Rewers, Marian [1 ,2 ]
Snell-Bergeon, Janet K. [1 ]
机构
[1] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA
[2] Colorado Sch Publ Hlth, Aurora, CO USA
[3] Clin Hosp Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil
基金
美国国家卫生研究院;
关键词
BODY-MASS INDEX; METABOLIC SYNDROME; INSULIN-RESISTANCE; COMPLICATIONS TRIAL; WEIGHT-GAIN; RISK-FACTOR; MELLITUS; PROGRESSION; PREVALENCE; COMPONENTS;
D O I
10.1089/dia.2011.0046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim was to examine whether excess weight is associated with coronary artery calcium (CAC), independent of metabolic parameters in adults with type 1 diabetes (T1D). Methods: Subjects between 19 and 56 years of age with T1D (n = 621) from the Coronary Artery Calcification in Type 1 Diabetes study were classified as abnormal on four metabolic parameters: blood pressure >= 130/85mm Hg or on antihypertensive treatment; high-density lipoprotein-cholesterol of <40mg/dL for men or <50mg/dL for women; triglycerides of >= 150 mg/dL; or C-reactive protein of >= 3 mu g/mL. Study participants with two or more abnormal parameters were classified as metabolically abnormal. Weight categories by body mass index were normal (< 25 kg/m(2)), overweight (25 to < 30 kg/m(2)), and obese (>= 30 kg/m(2)). CAC was measured at two visits 6.0 +/- 0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of >= 2.5mm(3) or development of clinical coronary artery disease. Results: Among subjects with T1D, 48% of normal, 61% of overweight, and 73% of obese participants were classified as metabolically abnormal (P < 0.0001). Overweight and obesity were independently associated with presence of CAC, independent of presence of metabolically abnormal. Obesity but not overweight was associated with CAC progression, independent of the other cardiovascular risk factors. Conclusions: Although obesity is known to increase cardiovascular disease risk through inducing metabolic abnormalities such as dyslipidemia, hypertension, and inflammation, it is also a strong predictor of subclinical atherosclerosis progression in adults with T1D independent of these factors.
引用
收藏
页码:991 / 996
页数:6
相关论文
共 50 条
[21]   Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: Results from the PREDICT study [J].
Mackness, Bharti ;
Marsillach, Judit ;
Elkeles, Robert S. ;
Godsland, Ian F. ;
Feher, Michael D. ;
Rubens, Michael B. ;
Flather, Marcus D. ;
Humphries, Steve E. ;
Cooper, Jackie ;
Mackness, Mike .
DISEASE MARKERS, 2012, 33 (02) :101-112
[22]   Associations of dietary patterns and nutrients with coronary artery calcification and pericardial adiposity in a longitudinal study of adults with and without type 1 diabetes [J].
Basu, Arpita ;
Chien, Lung-Chang ;
Alman, Amy C. ;
Snell-Bergeon, Janet K. .
EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (07) :3911-3925
[23]   Prepregnancy Cardiovascular Health, Gestational Diabetes, and Coronary Artery Calcium [J].
Cameron, Natalie A. ;
Petito, Lucia C. ;
Colangelo, Laura A. ;
Gunderson, Erica P. ;
Catov, Janet M. ;
Grobman, William A. ;
Rana, Jamal S. ;
Terry, James G. ;
Lloyd-Jones, Donald M. ;
Allen, Norrina B. ;
Khan, Sadiya S. .
JAMA CARDIOLOGY, 2025,
[24]   OSTEOPROTEGERIN IS A BETTER SERUM BIOMARKER OF CORONARY ARTERY CALCIFICATION THAN OSTEOCALCIN IN TYPE 2 DIABETES [J].
Maser, Raelene E. ;
Lenhard, M. James ;
Sneider, Michael B. ;
Pohlig, Ryan T. .
ENDOCRINE PRACTICE, 2015, 21 (01) :14-22
[25]   Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes [J].
Pratte, Katherine A. ;
Baron, Anna E. ;
Ogden, Lorraine G. ;
Hassell, Kathryn L. ;
Rewers, Marian ;
Hokanson, John E. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) :387-393
[26]   Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes [J].
Madrigal, Jessica M. ;
Monson, Rebecca S. ;
Hatipoglu, Betul ;
Oberholzer, Jose ;
Kondos, George T. ;
Varady, Krista A. ;
Danielson, Kirstie K. .
CLINICAL TRANSPLANTATION, 2017, 31 (10)
[27]   Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study [J].
Ferrannini, Giulia ;
Manca, Maria Laura ;
Magnoni, Marco ;
Andreotti, Felicita ;
Andreini, Daniele ;
Latini, Roberto ;
Maseri, Attilio ;
Maggioni, Aldo P. ;
Ostroff, Rachel M. ;
Williams, Stephen A. ;
Ferrannini, Ele .
DIABETES CARE, 2020, 43 (04) :843-851
[28]   The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus: Rationale and Design of RosCal Study [J].
Zhang, Wenbin ;
Luan, Yi ;
Jin, Chongying ;
Xu, Shengjie ;
Bi, Xukun ;
Zhao, Yanbo ;
Qiu, Fuyu ;
Fu, Guosheng ;
Wang, Min .
CLINICAL DRUG INVESTIGATION, 2016, 36 (12) :1023-1029
[29]   Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes [J].
Simpson, Melissa ;
Snell-Bergeon, Janet K. ;
Kinney, Gregory L. ;
Lache, Orit ;
Miller-Lotan, Rachel ;
Anbinder, Yefim ;
Rewers, Marian J. ;
Levy, Andrew P. .
CARDIOVASCULAR DIABETOLOGY, 2011, 10
[30]   Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study [J].
Bjornstad, Petter ;
Maahs, David M. ;
Duca, Lindsey M. ;
Pyle, Laura ;
Rewers, Marian ;
Johnson, Richard J. ;
Snell-Bergeon, Janet K. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (04) :586-590